Oragenics Inc. Files 8-K Report
Ticker: OGEN · Form: 8-K · Filed: Mar 27, 2025 · CIK: 1174940
Sentiment: neutral
Topics: 8-K, financial-statements, exhibits
TL;DR
Oragenics filed an 8-K with financial docs, nothing major yet.
AI Summary
On March 27, 2025, Oragenics Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, indicating a routine update or disclosure rather than a specific material event. No significant financial transactions or new business developments were detailed in the provided excerpt.
Why It Matters
This filing indicates Oragenics Inc. is providing updated financial statements and exhibits to the SEC, which is a standard requirement for public companies.
Risk Assessment
Risk Level: low — The filing appears to be a routine disclosure of financial statements and exhibits, with no immediate indication of significant new risks or material events.
Key Players & Entities
- Oragenics Inc. (company) — Registrant
- March 27, 2025 (date) — Date of report
- 1990 Main Street Suite 750 Sarasota, FL 34236 (address) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing by Oragenics Inc.?
The primary purpose of this 8-K filing by Oragenics Inc. is to report on 'Other Events' and 'Financial Statements and Exhibits' as of March 27, 2025.
What is the date of the earliest event reported in this filing?
The date of the earliest event reported in this filing is March 27, 2025.
What is the company's principal executive office address?
The company's principal executive office is located at 1990 Main Street Suite 750, Sarasota, FL 34236.
What is Oragenics Inc.'s telephone number?
Oragenics Inc.'s telephone number is 813-286-7900.
What is the Standard Industrial Classification (SIC) code for Oragenics Inc.?
The Standard Industrial Classification (SIC) code for Oragenics Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 27, 2025 regarding ORAGENICS INC (OGEN).